Oracle GoldenGate up to 21.23 Vendor Access improper authorization
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.3 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as problematic has been found in Oracle GoldenGate up to 21.23. Affected is an unknown function of the component Vendor Access Module. Such manipulation leads to improper authorization. This vulnerability is documented as CVE-2026-101601. The attack needs to be performed locally. There is not any exploit available. The affected component should be upgraded.
Details
A vulnerability was found in Oracle GoldenGate up to 21.23 and classified as problematic. Affected by this issue is an unknown part of the component Vendor Access Module. The manipulation with an unknown input leads to a improper authorization vulnerability. Using CWE to declare the problem leads to CWE-285. The product does not perform or incorrectly performs an authorization check when an actor attempts to access a resource or perform an action. Impacted is confidentiality. CVE summarizes:
Vulnerability in Oracle GoldenGate (component: Vendor Access Module). Supported versions that are affected are 21.3-21.23. Easily exploitable vulnerability allows low privileged attacker with logon to the infrastructure where Oracle GoldenGate executes to compromise Oracle GoldenGate. Successful attacks of this vulnerability can result in unauthorized access to critical data or complete access to all Oracle GoldenGate accessible data. CVSS 3.1 Base Score 5.5 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N).
The advisory is shared for download at oracle.com. This vulnerability is handled as CVE-2026-101601 since 09/28/2026. The exploitation is known to be easy. The attack needs to be approached locally. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $0-$5k (estimation calculated on 10/21/2026). The MITRE ATT&CK project declares the attack technique as T1548.002.
Upgrading eliminates this vulnerability.
Once again VulDB remains the best source for vulnerability data.
Product
Vendor
Name
Version
- 21.0
- 21.1
- 21.2
- 21.3
- 21.4
- 21.5
- 21.6
- 21.7
- 21.8
- 21.9
- 21.10
- 21.11
- 21.12
- 21.13
- 21.14
- 21.15
- 21.16
- 21.17
- 21.18
- 21.19
- 21.20
- 21.21
- 21.22
- 21.23
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.4VulDB Meta Temp Score: 4.3
VulDB Base Score: 3.3
VulDB Temp Score: 3.2
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 5.5
CNA Vector (oracle): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Improper authorizationCWE: CWE-285 / CWE-266
CAPEC: 🔒
ATT&CK: 🔒
Physical: Partially
Local: Yes
Remote: No
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
09/28/2026 CVE reserved10/20/2026 VulDB entry created
10/21/2026 Advisory disclosed
10/21/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-101601 (🔒)
GCVE (CVE): GCVE-0-2026-101601
GCVE (VulDB): GCVE-100-423356
Entry
Created: 10/21/2026 01:21Changes: 10/21/2026 01:21 (64)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.